Cargando…
Chronic Treatment with Multi-Kinase Inhibitors Causes Differential Toxicities on Skeletal and Cardiac Muscles
Despite recent progress, chemotherapy remains the preferred treatment for cancer. We have shown a link between anticancer drugs and the development of cachexia, i.e., body wasting accompanied by muscle loss. The multi-kinase inhibitors (MKIs) regorafenib and sorafenib, used as second-line treatment...
Autores principales: | Huot, Joshua R., Essex, Alyson L., Gutierrez, Maya, Barreto, Rafael, Wang, Meijing, Waning, David L., Plotkin, Lilian I., Bonetto, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6520777/ https://www.ncbi.nlm.nih.gov/pubmed/31018508 http://dx.doi.org/10.3390/cancers11040571 |
Ejemplares similares
-
miR21 deletion in osteocytes has direct and indirect effects on skeletal muscle in a sex-dimorphic manner in mice
por: Essex, Alyson L., et al.
Publicado: (2022) -
Bisphosphonate Treatment Ameliorates Chemotherapy-Induced Bone and Muscle Abnormalities in Young Mice
por: Essex, Alyson L., et al.
Publicado: (2019) -
MC38 Tumors Induce Musculoskeletal Defects in Colorectal Cancer
por: Huot, Joshua R., et al.
Publicado: (2021) -
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) R47H Variant Causes Distinct Age‐ and Sex‐Dependent Musculoskeletal Alterations in Mice
por: Essex, Alyson L., et al.
Publicado: (2022) -
Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs
por: Barreto, Rafael, et al.
Publicado: (2016)